Pfizer, an American biopharmaceutical company, has stated that its COVID-19 vaccine could be ready for emergency use by September.
The pharmaceutical giant said it will begin testing of the experimental vaccine in the US next week.
This is coming a week after Germany approved human trial of a possible COVID-19 vaccine. The vaccine, named BNT162, was developed by Biontech, a Mainz-based company.
The United Kingdom had also announced that there would be clinical trials of a potential COVID-19 vaccine.
The World Health Organisation (WHO) said there are about 20 different potential COVID-19 vaccines currently in development.
Some of the companies working on a vaccine said they are accelerating the timeline for testing as experts predict that the COVID-19 pandemic may last till 2021.
51 total views, 1 views today